Göke R, Conlon J M
Clinical Research Group for Gastrointestinal Endocrinology, University of Göttingen, Federal Republic of Germany.
J Endocrinol. 1988 Mar;116(3):357-62. doi: 10.1677/joe.0.1160357.
Specific binding of 125I-labelled glucagon-like peptide-1(7-36)amide (GLP-1(7-36)amide) to rat insulinoma-derived RINm5F cells was dependent upon time and temperature and was proportional to cell concentration. Binding of radioactivity was inhibited in a concentration-dependent manner by GLP-1(7-36) amide consistent with the presence of a single class of binding site with a dissociation constant (Kd) of 204 +/- 8 pmol/l (mean +/- S.E.M.). Binding of the peptide resulted in a dose-dependent increase in cyclic AMP concentrations (half maximal response at 250 +/- 20 pmol/l). GLP-1(1-36)amide was approximately 200 times less potent than GLP-1(7-36)amide in inhibiting the binding of 125I-labelled GLP-1(7-36)amide to the cells (Kd of 45 +/- 6 nmol/l). Binding sites for GLP-1 (7-36)amide were not present on dispersed enterocytes from porcine small intestine.
125I标记的胰高血糖素样肽-1(7-36)酰胺(GLP-1(7-36)酰胺)与大鼠胰岛素瘤来源的RINm5F细胞的特异性结合取决于时间和温度,且与细胞浓度成正比。放射性的结合受到GLP-1(7-36)酰胺浓度依赖性的抑制,这与存在一类解离常数(Kd)为204±8 pmol/L(平均值±标准误)的单一结合位点一致。该肽的结合导致环磷酸腺苷浓度呈剂量依赖性增加(在250±20 pmol/L时达到最大反应的一半)。GLP-1(1-36)酰胺在抑制125I标记的GLP-1(7-36)酰胺与细胞结合方面的效力约为GLP-1(7-36)酰胺的200倍(Kd为45±6 nmol/L)。猪小肠分散的肠上皮细胞上不存在GLP-1(7-36)酰胺的结合位点。